16 Laurel Avenue
5 articles with NormOxys, Inc.
NormOxys, Inc.' Novel Oxygen-Enhancing Drug Candidate, OXY111A, Recognized as One of Windhover Information Inc.'s Top 10 Cardiovascular/Metabolic Projects to Watch
NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
NormOxys, Inc. Secures $17.5 Million Series B Financing to Advance Lead Drug Candidate into Clinical Studies for Two Diseases